(Q35061441)

6 August 2017

title

Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia (English)

1 reference

6 August 2017

1 reference

Harvey Whiteford

3

0 references

Theo Vos

series ordinal

2

object named as

Theo Vos

1 reference

6 August 2017

Pudtan Phanthunane

1

1 reference

6 August 2017

Melanie Bertram

series ordinal

4

1 reference

6 August 2017

publication date

13 May 2011

1 reference

Cost Effectiveness and Resource Allocation

6 August 2017

published in

1 reference

6 August 2017

volume

9

1 reference

6 August 2017

page(s)

6

1 reference

Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in Thailand

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Packages of care for schizophrenia in low- and middle-income countries

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Clozapine versus typical neuroleptic medication for schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Economic burden of schizophrenia in South Korea

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Adjunctive psychosocial therapies for the treatment of schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Cost-effectiveness of antipsychotics for outpatients with chronic schizophrenia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Subjective and objective quality of life in schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Antipsychotic medication adherence in schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Chlorpromazine versus placebo for schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Strategies for maximizing clinical effectiveness in the treatment of schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Haloperidol versus placebo for schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health Organization

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Pharmacoeconomic modelling in schizophrenia. Trap or support for decision makers?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Olanzapine for schizophrenia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Antipsychotic-induced weight gain: a comprehensive research synthesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

The impact of psychiatric disorders on work loss days

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Suicide as an outcome for mental disorders. A meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

The cost of schizophrenia treatment in Taiwan

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7547-9-6

The functionality and economic costs of outpatients with schizophrenia in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7547-9-6

Psychoeducation program for chinese family carers of members with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7547-9-6

Self-stigma of people with schizophrenia as predictor of their adherence to psychosocial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7547-9-6

Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7547-9-6

Relationships between cognitive deficits, symptoms and quality of life in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7547-9-6

Health outcomes of schizophrenia in Thailand: Health care provider and patient perspectives.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Economic evaluation of antipsychotic drugs for schizophrenia treatment within the Brazilian Healthcare System

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

A population-based cost-effectiveness analysis of olanzapine and risperidone among ambulatory patients with schizophrenia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Assessing cost-effectiveness in mental health: helping policy-makers prioritize and plan health services

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Cost of care of schizophrenia: a study of Indian out-patient attenders

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Assessing cost-effectiveness of drug interventions for schizophrenia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Assessing Cost-Effectiveness--Mental Health: introduction to the study and methods.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

The global costs of schizophrenia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Risperidone versus typical antipsychotic medication for schizophrenia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3120770

Modelling approaches: the case of schizophrenia

16 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21569448

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21569448

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Excess mortality of mental disorder

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21569448

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1478-7547-9-6

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference

6 August 2017

1 reference